Darnytsia Supports Doctors at the XXVI National Congress of Cardiologists of Ukraine
Darnytsia Pharmaceutical Company became an active participant in the XXVI National Congress of Cardiologists of Ukraine, where doctors gathered to discuss the most pressing issues in cardiovascular medicine.
Cardiovascular diseases have remained the leading cause of death for many years, both in Ukraine and globally. According to the Ministry of Health of Ukraine, about 65% of all deaths in the country are due to cardiovascular diseases, and annually, these conditions claim more than 350,000 Ukrainian lives. Globally, according to the World Health Organization, circulatory system diseases take over 17 million lives each year. The most common of these diseases are coronary heart disease, myocardial infarction, stroke, and arterial hypertension. Key risk factors include stress, poor diet, sedentary lifestyle, and excessive workload.
A special feature of the Congress was the branded Darnytsia stand, where doctors could challenge stereotypes about Ukrainian medicines. In an interactive format, they created a map of Ukraine, marking their regions and sharing why they value Darnytsia's medicines: for quality, efficacy, optimal price-to-quality ratio, confidence in the products, and Ukrainian production.
At the stand, doctors were also able to try on Ukrainian tiaras—decorative headpieces that have historically symbolized status and honor in many cultures. This interactive element not only added cultural depth to the event, but also served as a bridge between tradition and modern Ukrainian pharmaceuticals, demonstrating the value of domestic production in all its manifestations.
“Our goal is to change perceptions of Ukrainian pharmaceuticals: we prove that it is possible to produce high-quality, effective medicines in Ukraine. We select only the best raw materials, our products undergo clinical trials and comply with international standards. Darnytsia was the first in Ukraine to receive a GMP certificate, and today continues to confirm this in the EU. Every day, we keep working to provide Ukrainians with Darnytsia medicines trusted worldwide,” noted Svitlana Maksymova, Rx Sales & Marketing Department Director at Darnytsia.
Darnytsia believes that the heart health of Ukrainians is a shared responsibility of pharmaceutical companies and the medical community. Together, we are building a healthcare system where Ukrainians can access help according to the most advanced standards, and doctors feel confident and supported in their daily work.
